Log In
BCIQ
Print this Print this
 

Anti-Ebola virus nanoviricides

  Manage Alerts
Collapse Summary General Information
Company NanoViricides Inc.
DescriptionNanoviricides targeting Ebola virus envelope proteins
Molecular Target
Mechanism of Action 
Therapeutic ModalityNanotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationEbola
Indication DetailsTreat Ebola virus infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today